A woman in her 30s, who was 19 weeks pregnant with twins in her womb, collapsed and died of a rare blood disease and despite the efforts of the medical staff at Tel Aviv's Ichilov Hospital, both fetuses also died, according to Yediot Ahronot.
A new, life-saving drug, approved by the United States Food and Drug Administration but not yet registered to enter the 2020 drug basket in Israel was rushed at the request of doctors with extraordinary approval of the Health Ministry but did not arrive in time. The rare disease is called TTP (Thrombotic thrombocytopenic purpura) that results in blood clots forming in small blood vessels throughout the body. In Israel, between 20 and 30 people are affected each year. The symptoms are fever, headaches and a bad general feeling. Rash appears on the skin and there is a sharp and dangerous drop in platelet levels.